Although extensive evidence shows an association between MMP-9 expression and HT [94,102] particularly after administration of intravenous thrombolysis [55,95,107], the effect of MMP-9 polymorphisms on HT susceptibility is unclear. The gene discussed is MMP9; the disease is hematocrit.